参考文献/References:
[1] Prabhu S,Voskoboinik A,Kaye DM,et al. Atrial Fibrillation and heart failure—cause or effect?[J]. Heart Lung Circ,2017,26(9):967-974.
[2] Packer DL,Mark DB,Robb RA,et al. Effect of catheter ablation vs antiarrhythmic drug therapy on mortality,stroke,bleeding,and cardiac arrest among patients with atrial fibrillation[J]. JAMA,2019,321(13):1261.
[3] Writing Group Members,January CT,Wann LS,et al. 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation:a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society[J]. Heart Rhythm,2019,16(8):e66-e93.
[4] Kirchhof P,Benussi S,Kotecha D,et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS[J]. Eur Heart J,2016,50(5):e1-e88.
[5] 黄从新,张澍,黄德嘉,等. 心房颤动:目前的认识和治疗的建议-2018[J]. 中国心脏起搏与心电生理杂志,2018,32(4):315-368.
[6]Hsu LF, Ja?s P, Sanders P,et al. Catheter ablation for atrial fibrillation in congestive heart failure[J]. N Engl J Med ,2004,351(23):2373-2383.
[7]Chen MS, Marrouche NF, Khaykin Y,et al. Pulmonary vein isolation for the treatment of atrial fibrillation in patients with impaired systolic function[J]. J Am Coll Cardiol,2004,43(6):1004-1009.
[8]Khan MN, Ja?s P, Cummings J, et al. Pulmonary-vein isolation for atrial fibrillation in patients with heart failure[J]. N Engl J Med,23,359(17):1778-1785.
[9]MacDonald MR, Connelly DT, Hawkins NM, et al. Radiofrequency ablation for persistent atrial fibrillation in patients with advanced heart failure and severe left ventricular systolic dysfunction: a randomised controlled trial[J]. Heart,2011,97(9):740-747.
[10]Jones DG, Haldar SK, Hussain W, et al. A randomized trial to assess catheter ablation versus rate control in the management of persistent atrial fibrillation in heart failure[J]. J Am Coll Cardiol,2013,61(18):1894-1903.
[11] Hunter RJ,Berriman TJ,Diab I,et al. A randomized controlled trial of catheter ablation versus medical treatment of atrial fibrillation in heart failure (The CAMTAF trial)[J]. Circ Arrhythm Electrophysiol,2014,7(1):31-38.
[12] di Biase L,Mohanty P,Mohanty S,et al. Ablation versus amiodarone for treatment of persistent atrial fibrillation in patients with congestive heart failure and an implanted device[J]. Circulation,2016,133(17):1637-1644.
[13] Lip GYH,Heinzel FR,Gaita F,et al. European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure,endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society[J]. EP Europace,2015,18(1):12-36.
[14] Gonna H,Domenichini G,Zuberi Z,et al. Initial clinical results with the ThermoCool? SmartTouch? Surround Flow catheter[J]. EP Europace,2017,19(8):1317-1321.
[15] Dhillon G,Ahsan S,Honarbakhsh S,et al. A multicentered evaluation of ablation at higher power guided by ablation index:Establishing ablation targets for pulmonary vein isolation[J]. J Cardiovasc Electrophysiol,2018,30(3):357-365.
[16] Winkle RA,Mohanty S,Patrawala RA,et al. Low complication rates using high power (45-50 W) for short duration for atrial fibrillation ablation s[J]. Heart Rhythm,2019,16(2):165-169.
[17] Reddy VY,Grimaldi M,de Potter T,et al. Pulmonary vein isolation with very?high?power,short duration,temperature-controlled lesions:The QDOT-FAST Trial[J]. JACC Clin Electrophysiol,2019,5(7):778-786.
[18] Solimene F,Schillaci V,Shopova G,et al. Safety and efficacy of atrial fibrillation ablation guided by Ablation Index module[J].J Interv Card Electrophysiol,2019,54(1):9-15.
[19] Marrouche NF,Brachmann J,Andresen D,et al. Catheter ablation for atrial fibrillation with heart failure[J]. N Engl J Med,2018,378(5):417-427.
[20] Kuck KH,Merkely B,Zahn R,et al. Catheter ablation versus best medical therapy in patients with persistent atrial fibrillation and congestive heart failure:the randomized AMICA trial[J]. Circ Arrhythm Electrophysiol,2019,12(12):e007731.
[21] Brice?o DF,Markman TM,Lupercio F,et al. Catheter ablation versus conventional treatment of atrial fibrillation in patients with heart failure with reduced ejection fraction:a systematic review and meta-analysis of randomized controlled trials[J]. J Interv Card Electrophysiol,2018,53(1):19-29.
[22] Long S,Xi Y,Gao L,et al. Safety and efficacy of catheter ablation in atrial fibrillation patients with left ventricular dysfunction[J]. Clin Cardiol,2019,43(3):305-314.
[23] Ponikowski P,Voors AA,Anker SD,et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure:The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC[J]. Eur Heart J,2016,37(27):2129-2200.
[24] Santhanakrishnan R,Wang N,Larson MG,et al. Atrial fibrillation begets heart failure and vice versa[J]. Circulation,2016,133(5):484-492.
[25] Franco J,Formiga F,Cepeda J,et al. Influence of atrial fibrillation on the mortality of patients with heart failure with preserved ejection fraction[J]. Med Clin (Barc),2018,150(10):376-382.
[26] Melenovsky V,Hwang S,Redfield MM,et al. Left atrial remodeling and function in advanced heart failure with preserved or reduced ejection fraction[J]. Circ Heart Fail,2015,8(2):295-303.
[27]Patel RB, Vaduganathan M, Shah SJ, et al. Atrial fibrillation in heart failure with preserved ejection fraction: Insights into mechanisms and therapeutics[J]. Pharmacol Ther,2017,176:32-39.
[28] Black-Maier E,Ren X,Steinberg BA,et al. Catheter ablation of atrial fibrillation in patients with heart failure and preserved ejection fraction[J]. Heart Rhythm,2018,15(5):651-657.
[29] Fukui A,Tanino T,Yamaguchi T,et al. Catheter ablation of atrial fibrillation reduces heart failure rehospitalization in patients with heart failure with preserved ejection fraction[J]. J Cardiovasc Electrophysiol,2020,31(3):682-688.
[30] Kelly JP,Devore AD,Wu J,et al. Rhythm control versus rate control in patients with atrial fibrillation and heart failure with preserved ejection fraction:insights from get with the guidelines—heart failure[J]. J Am Heart Assoc,2019,8(24):e011560.
[31] Machino-Ohtsuka T,Seo Y,Ishizu T,et al. Efficacy,safety,and outcomes of catheter ablation of atrial fibrillation in patients with heart failure with preserved ejection fraction[J]. J Am Coll Cardiol,2013,62(20):1857-1865.
[32] Machino-Ohtsuka T,Seo Y,Ishizu T,et al. Relationships between maintenance of sinus rhythm and clinical outcomes in patients with heart failure with preserved ejection fraction and atrial fibrillation[J]. J Cardiol,2019,74(3):235-244.
[33] Vecchio N,Ripa L,Orosco A,et al. Atrial fibrillation in heart failure patients with preserved or reduced ejection fraction. prognostic significance of rhythm control strategy with catheter ablation[J]. J Atr Fibrillation,2019,11(5):2128.
[34] Kotecha D,Chudasama R,Lane D A,et al. Atrial fibrillation and heart failure due to reduced versus preserved ejection fraction:a systematic review and meta-analysis of death and adverse outcomes[J]. Int J Cardiol,2016,203:660-666.
[35] Huang W,Su L,Wu S,et al. Benefits of permanent his bundle pacing combined with atrioventricular node ablation in atrial fibrillation patients with heart failure with both preserved and reduced left ventricular ejection fraction[J]. J Am Heart Assoc,2017,6(4):e005309.
[36] Magnusson P,M?rner S,Gadler F,et al. Health-related quality of life in hypertrophic cardiomyopathy patients with implantable defibrillators[J]. Health Qual Life Outcomes,2016,14:62.
[37] Rowin EJ,Hausvater A,Link MS,et al. Clinical profile and consequences of atrial fibrillation in hypertrophic cardiomyopathy[J]. Circulation,2017,136(25):2420-2436.
[38] Vollmar C,Vollmar A,Keene BW,et al. Dilated cardiomyopathy in 151 Irish Wolfhounds:characteristic clinical findings,life expectancy and causes of death[J]. Vet J,2019,245:15-21.
[39] Zhao L,Xu K,Jiang W,et al. Long-term outcomes of catheter ablation of atrial fibrillation in dilated cardiomyopathy[J]. Int J Cardiol,2015,190:227-232.
[40] Sohinki D,Ho J,Srinivasan N,et al. Outcomes after atrioventricular node ablation and biventricular pacing in patients with refractory atrial fibrillation and heart failure:a comparison between non-ischaemic and ischaemic cardiomyopathy[J]. EP Europace,2014,16(6):880-886.
[41] Deshmukh A,Kim G,Burke M,et al. Atrial arrhythmias and electroanatomical remodeling in patients with left ventricular assist devices[J].J Am Heart Assoc,2017,6(3):e005340.
[42] Pedde D,Soltani S,Stein J,et al. Impact of preoperative atrial fibrillation on thromboembolic events and pump thrombosis in long-term left ventricular assist device therapy[J]. Eur J Cardiothorac Surg,2020,57(2):325-330.
[43] Kurihara C,Critsinelis A,Kawabori M,et al. Effect of preoperative atrial fibrillation on patients with chronic heart failure who undergo long-term continuous-flow LVAD implantatio n[J]. ASAIO J,2018,64(5):594-600.
相似文献/References:
[1]贺鹏康,周菁.心房颤动治疗新技术——冷冻球囊消融[J].心血管病学进展,2016,(1):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
HE Pengkang,ZHOU Jing.Cryoballoon Ablation, A Novel Technology for Atrial Fibrillation Treatment[J].Advances in Cardiovascular Diseases,2016,(4):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
[2]都明辉,施海峰*,佟佳宾,等.心房颤动消融相关性无症状性脑缺血[J].心血管病学进展,2016,(1):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
DU Minghui,SHI Haifeng*,TONG Jiabin,et al.Silent Cerebral Ischemia Related to Atrial Fibrillation Ablation[J].Advances in Cardiovascular Diseases,2016,(4):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
[3]丁娟,刘地川.心力衰竭与线粒体功能障碍的研究进展[J].心血管病学进展,2016,(1):84.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.022]
DING Juan,LIU Dichuan.Research Progress of Heart Failure and Mitochondrial Dysfunction[J].Advances in Cardiovascular Diseases,2016,(4):84.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.022]
[4]郑环杰,综述,肖骅,等.心房颤动抗栓治疗研究进展[J].心血管病学进展,2016,(2):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
ZHENG Huanjie,XIAO Hua.Progress of Antithrombotic Therapy in Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(4):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
[5]张清,综述,罗素新,等.新型Xa 因子抑制剂———依度沙班在心房颤动患者抗凝治疗中的研究进展[J].心血管病学进展,2016,(2):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
ZHANG Qing,LUO Suxin,TANG Jiong.Novel Factor Xa Inhibitors—Edoxaban in Prevention of Stroke in
Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(4):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
[6]胡红玲,综述,罗素新,等.预防非瓣膜性心房颤动性脑卒中的治疗新进展[J].心血管病学进展,2016,(3):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
HU Hongling,LUO Suxin.New Progress in the Treatment for Cerebral Apoplexy of Nonvalvular
Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(4):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
[7]王超,杨国澍,综述,等.关附甲素治疗心房颤动的研究进展[J].心血管病学进展,2016,(3):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
WANG Chao,YANG Guoshu,CAI Lin,et al.Research Progress of the Treatment of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(4):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
[8]罗秀林,综述,张烁,等.肾动脉去交感神经术治疗心力衰竭——希望还是炒作[J].心血管病学进展,2016,(3):268.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.013]
LUO Xiulin,ZHANG Shuo.Renal Sympathetic Denervation for Heart Failure—Hopes or Hypes[J].Advances in Cardiovascular Diseases,2016,(4):268.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.013]
[9]查凤艳,综述,覃数,等.心源性恶病质发病机制的研究进展[J].心血管病学进展,2016,(3):282.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.017]
ZHA Fengyan,QIN Shu.Advances in Pathogenesis of Cardiac Cachexia[J].Advances in Cardiovascular Diseases,2016,(4):282.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.017]
[10]李慧,综述,齐国先,等.老年射血分数保留的心功能不全研究进展[J].心血管病学进展,2016,(4):354.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.007]
LI Hui,QI Guoxian.Research Progress of Heart Failure with Preserved Ejection Fraction in Elderly People[J].Advances in Cardiovascular Diseases,2016,(4):354.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.007]
[11]吴彤 高东来.心房颤动合并心力衰竭的射频消融治疗[J].心血管病学进展,2019,(5):757.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.023]
WU TongGAO Donglai.Catheter Ablation of Atrial Fibrillation in Patients with Heart Failure[J].Advances in Cardiovascular Diseases,2019,(4):757.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.023]
[12]鲁星琴 莫乔莹 陈凤梅 姚亚丽.睡眠呼吸障碍与心力衰竭并发心房颤动的相关性研究现状[J].心血管病学进展,2020,(2):182.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.021]
LU Xingqin,MO Qiaoying,CHENG Fengmei,et al.Research Status of Association Between Sleep-disordered Breathing and Atrial Fibrillation in Patients with Heart Failure[J].Advances in Cardiovascular Diseases,2020,(4):182.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.021]
[13]史云聪,王立立 郭艺芳.维生素D与心血管疾病相关性研究进展[J].心血管病学进展,2020,(8):826.[doi:10.16806/j.cnki.issn.1004-3934.20.08.011]
SHI YuncongWANG LiliGUO Yifang.Vitamin D And Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2020,(4):826.[doi:10.16806/j.cnki.issn.1004-3934.20.08.011]
[14]李英 刘兴鹏.常见心血管病服药依从性[J].心血管病学进展,2020,(10):1016.[doi:10.16806/j.cnki.issn.1004-3934.2020.10.000]
LI Ying,LIU Xingpeng.Medication Adherence For Common Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2020,(4):1016.[doi:10.16806/j.cnki.issn.1004-3934.2020.10.000]
[15]刘玉辉 王盼盼 陈椿.心房颤动性心肌病临床研究进展[J].心血管病学进展,2020,(12):1238.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.004]
LIU Yuhui,WANG Panpan,CHEN Chun.Atrial Fibrillation-induced Cardiomyopathy[J].Advances in Cardiovascular Diseases,2020,(4):1238.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.004]
[16]徐尧 蔡衡 李洪仕.射频消融与药物治疗对心房颤动合并心力衰竭患者的疗效差异比较[J].心血管病学进展,2022,(3):274.[doi:10.16806/j.cnki.issn.1004-3934.2022.03.000]
[17]乔宝 魏述建.心房衰竭的临床研究进展[J].心血管病学进展,2024,(1):57.[doi:10.16806/j.cnki.issn.1004-3934.2024.01.015]
QIAO Bao,WEI Shujian.Progress of Clinical Research on Atrial Failure[J].Advances in Cardiovascular Diseases,2024,(4):57.[doi:10.16806/j.cnki.issn.1004-3934.2024.01.015]
[18]陈建福 陈灿.血压目标范围内时间与心血管疾病关系的研究进展[J].心血管病学进展,2024,(7):617.[doi:10.16806/j.cnki.issn.1004-3934.2024.07.010]
CHEN Jianfu,CHEN Can.The Relationship Between Time in Target Range and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2024,(4):617.[doi:10.16806/j.cnki.issn.1004-3934.2024.07.010]
[19]张琛玥 芦颜美 汤宝鹏.心房肺静脉牵张在慢性心力衰竭合并心房颤动中的作用与相关治疗的研究进展[J].心血管病学进展,2024,(10):897.[doi:10.16806/j.cnki.issn.1004-3934.2024.10.007]
ZHANG Chenyue,LU Yanmei,TANG Baopeng?/html>.The Role and Related Treatment of Atrial Pulmonary Vein Stretch in Chronic Heart Failure Complicated with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2024,(4):897.[doi:10.16806/j.cnki.issn.1004-3934.2024.10.007]